Voyager Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-42.5M | $-47.5M | $5.0M | $6.3M |
| FY2017 | $-61.4M | $-65.3M | $4.0M | $9.2M |
| FY2018 | $-15.9M | $-20.2M | $4.3M | $15.7M |
| FY2019 | $48.7M | $40.9M | $7.7M | $15.6M |
| FY2020 | $-96.7M | $-108.8M | $12.1M | $14.9M |
| FY2021 | $-53.5M | $-55.1M | $1.6M | $11.3M |
| FY2022 | $-12.5M | $-15.0M | $2.5M | $9.3M |
| FY2023 | $77.9M | $74.7M | $3.3M | $11.2M |
| FY2024 | $-15.3M | $-18.8M | $3.5M | $14.8M |
| FY2025 | $-132.5M | $-135.1M | $2.6M | $14.8M |